Cited by 2,001CRISPR and Genetic EngineeringVirus-based gene therapy researchRNA regulation and disease

CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling

Open access
Platt, Randall J., Chen, Sidi, Zhou, Yang, Yim, Michael J., Swiech, Lukasz, Kempton, Hannah R., Dahlman, James E., Parnas, Oren +13 more·2014·Cell

Abstract

CRISPR-Cas9 is a versatile genome editing technology for studying the functions of genetic elements. To broadly enable the application of Cas9 in vivo, we established a Cre-dependent Cas9 knockin mouse. We demonstrated in vivo as well as ex vivo genome editing using adeno-associated virus (AAV)-, lentivirus-, or particle-mediated delivery of guide RNA in neurons, immune cells, and endothelial cells. Using these mice, we simultaneously modeled the dynamics of KRAS, p53, and LKB1, the top three significantly mutated genes in lung adenocarcinoma. Delivery of a single AAV vector in the lung generated loss-of-function mutations in p53 and Lkb1, as well as homology-directed repair-mediated Kras(G12D) mutations, leading to macroscopic tumors of adenocarcinoma pathology. Together, these results suggest that Cas9 mice empower a wide range of biological and disease modeling applications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2014.09.014

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Delivery of next-generation CRISPR tools by lentivirus or ribonucleoprotein complexes may be a suitable alternative strategy to DNA mutations in adult stem cells.

    “Thus, delivery of next-generation CRISPR tools by lentivirus or ribonucleoprotein complexes may be a suitable alternative strategy to DNA mutations in adult stem cells.54,55,56”

    From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [56]

    The Results section on ex vivo genome editing reports that lentiviral delivery of guide RNAs produced mutations in primary mouse dendritic cells. It does not establish ribonucleoprotein delivery or the proposed strategy in adult stem cells, nor does it describe genome editing as an alternative to DNA mutations. Page numbers are unavailable in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Cas9-dependent acute deletion of the Spi1 locus can be fast and highly efficient due to availability of Cas9-transgenic mice and vectors for high-level, synchronous guide RNA expression.

    “Cas9-dependent acute deletion of the Spi1 locus can be fast and highly efficient due to the availability of Cas9-transgenic mice (92) and vectors that can be used for high-level, synchronous expression of guide RNAs.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Lewandoski M Meyers EN Martin GR Analysis of Fgf8 gene function in vertebrate development. Cold Spring Harb. Symp. Quant. Biol 1997 62 159 168 9598348

Cited by

Sorted by citations

Authors
Platt, R. J., Chen, S., Zhou, Y., Yim, M. J., Swiech, L., Kempton, H. R., Dahlman, J. E., Parnas, O., Eisenhaure, T. M., Jovanovic, M., Graham, D. B., Jhunjhunwala, S., Heidenreich, M., Xavier, R. J., Langer, R., Anderson, D. G., Hacohen, N., Regev, A., Feng, G., Sharp, P. A., & Zhang, F.
Affiliations
  • Broad Institute (US)
  • Koch Institute for Integrative Cancer Research At MIT (US)
  • McGovern Institute for Brain Research (US)
  • Harvard–MIT Division of Health Sciences and Technology (US)
Corresponding author
  • Sharp, Phillip A.
  • Zhang, Feng
Venue
Cell
Publisher
Elsevier BV
Published
2014-10
Volume
159
Issue
2
Pages
440-455
ISSN
0092-8674 (ISSN-L)
OpenAlex
W1972476556
Cited by
2,001
References
70
Citations by year
2026: 121 · 2025: 162 · 2024: 191 · 2023: 188 · 2022: 202 · 2021: 179 · 2020: 190 · 2019: 171 · 2018: 175 · 2017: 159 · 2016: 140 · 2015: 108 · 2014: 9 · 2013: 1
FWCI
56.82
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
  • PMC
Funders
  • Howard Hughes Medical Institute
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • National Institutes of Health (4r37eb000244-34)
  • National Institute of Mental Health (DP1MH100706)
  • National Human Genome Research Institute (P50HG006193)
  • National Cancer Institute (R01CA133404, U54CA151884, P30CA014051, P30-CA-14051)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK097768, DK 43351, P30DK043351)
  • National Institute of Neurological Disorders and Stroke (R01NS073124)
  • National Institute of Biomedical Imaging and Bioengineering (EB-000244, R37-EB000244)
  • National Center for Chronic Disease Prevention and Health Promotion (DP1‑MH100706)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords
CRISPR/Cas9, knock-in mice, in vivo gene editing, adeno-associated virus vectors, guide RNA delivery, lung adenocarcinoma, KRAS G12D, p53, LKB1, tumor modeling, homology-directed repair, neurons, immune cells, endothelial cells
MeSH terms
Adenocarcinoma, Animals, Dendritic Cells, Disease Models, Animal, Genetic Engineering, Genetic Vectors, Lung Neoplasms, Mice, Transgenic, Oncogenes, Lentivirus, Genes, Tumor Suppressor, Mice, Gene Knock-In Techniques, Clustered Regularly Interspaced Short Palindromic Repeats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review